Bluebird to Present Follow-Up Data for CAR T-cell Therapy in Advanced Multiple Myeloma Patients – Myeloma Research News
Myeloma Research News |
Bluebird to Present Follow-Up Data for CAR T-cell Therapy in Advanced Multiple Myeloma Patients
Myeloma Research News Patients with advanced multiple myeloma who received three or more lines of therapy have shown promising safety and efficacy results in a Phase 1 trial assessing bluebird bio's new CAR T-cell therapy bb2121. New data, to be presented at the American … |
